These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3239222)

  • 1. [The immediate and late results of treating neurodermatitis by the indirect endolymphatic administration of drug preparations].
    Shakhtmeĭster IIa; Pisarenko MF
    Vestn Dermatol Venerol; 1988; (11):12-3. PubMed ID: 3239222
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunocorrection with T-activin in the combined treatment of juvenile rheumatoid arthritis].
    Melikhova NI; Kuz'mina NN; Chirkin VV; Arion VIa; Baryshkov IuA
    Revmatologiia (Mosk); 1987; (3):19-23. PubMed ID: 3317708
    [No Abstract]   [Full Text] [Related]  

  • 3. [The intraperitoneal administration of chemical preparations and taktivin in the combined treatment of stomach cancer].
    Shchepotin IB; Chernyĭ VA; Grinevich IuA; Kamenets LIa; Osinskiĭ SP
    Vrach Delo; 1988 Sep; (9):3-6. PubMed ID: 3212989
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prophylaxis of purulent complications in operations on large joints by endolymphatic infusion of drugs].
    Vyrenkov IuE; Dmitriev AE; Murylev VIu; Zorokhovich OL; Shishlo VK; Vtorenko VI
    Khirurgiia (Mosk); 1998; (12):45-7. PubMed ID: 9916435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endolymphatic therapy in the treatment of patients with acute appendicitis].
    Komarov NV; Kanashkin OV; Bagrov NA; Maslagin AS
    Klin Khir; 1996; (1):53. PubMed ID: 8829817
    [No Abstract]   [Full Text] [Related]  

  • 6. [Indications for the use of tactivin in the combined treatment of phlegmons of the maxillofacial area].
    Drobyshev VIu; Volozhin AI; Agapov VS; Sashkina TI
    Stomatologiia (Mosk); 1996; 75(4):27-30. PubMed ID: 8992659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of vilozen in treating patients with vasculitis of different origins].
    Ialkut SI; Kotova SA; Evseeva TA; Golubenko GM; Bezvershenko IA
    Vrach Delo; 1990 Aug; (8):25-6. PubMed ID: 2256277
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of the effectiveness of immunomodulating preparations in combined therapy of chronic obstructive bronchitis].
    Shilov VA; Shirinskiĭ VS
    Klin Med (Mosk); 1995; 73(4):88-90. PubMed ID: 7474838
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of T-activin and thymalin in the treatment of ophthalmic herpes].
    Mal'khanov VB; Gripas' IA; Nasibullina GKh; Belousova MA
    Vestn Oftalmol; 1991; 107(5):51-4. PubMed ID: 1763455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intralymphatic drug therapy--a pathogenetically substantiated method of treatment in peritonitis].
    Kuliev SH; Achundov IT
    Khirurgiia (Mosk); 1992; (9-10):29-35. PubMed ID: 1282164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of T-activin and prodigiozan in combined treatment of patients with diabetic retinopathy].
    Sakalo EA; Malyzhev VA; Danilova AI
    Oftalmol Zh; 1988; (4):204-7. PubMed ID: 3263597
    [No Abstract]   [Full Text] [Related]  

  • 12. [Taktivin treatment of immunologic disorders in patients with nonspecific ulcerative colitis].
    Shafer NP
    Klin Med (Mosk); 1993; 71(3):45-7. PubMed ID: 8015217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A lymphotropic method of antibiotic administration in treating patients with chronic prostatitis].
    Aleksandrov VP; Mikhaĭlichenko VV; Pecherskiĭ AV
    Urol Nefrol (Mosk); 1998; (5):22-4. PubMed ID: 9820041
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative effectiveness of current pathogenetic methods of treating neurodermatitis].
    Grebennikov VA; Eremina SA; Terekhov EM
    Vestn Dermatol Venerol; 1989; (5):35-9. PubMed ID: 2773579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of a dialysable nonpolypeptide thymus factor for treating neurodermatitis].
    Glukhen'kiĭ BT; Bezvershenko IA; Panchenko NA; Boĭko IuIa; Glukhen' kaia AB
    Vrach Delo; 1981 Sep; (9):110-3. PubMed ID: 7303600
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of the efficacy of topical and subcutaneous administration of tactivin for correcting secondary immunodeficiencies of young children].
    Arion VIa; Bekman EM; Tiurin NA; Mazurina NA; Filimonova AV
    Biull Eksp Biol Med; 1994 Nov; 118(11):496-8. PubMed ID: 7888649
    [No Abstract]   [Full Text] [Related]  

  • 17. Application-dependent immunomodulating and antimetastatic efficacy of thymic peptides in BALB/c-mice.
    Beuth J; Schierholz JM; Ko HL; Braun JM
    In Vivo; 2001; 15(5):403-6. PubMed ID: 11695237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic correction in the treatment of chronic hematogenic osteomyelitis of long tubular bones in children].
    Samsygin SA; Schastnyĭ SA; Vlasenko VV; Dolgina EN; Ekk ND
    Vestn Akad Med Nauk SSSR; 1991; (12):50-4. PubMed ID: 1801475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of thymotropin on neuroendocrine regulation of the humoral immunity link in patient with neurodermatitis].
    Khamidov ShA
    Vestn Dermatol Venerol; 1988; (11):17-9. PubMed ID: 2853501
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of prodigiozan and tactivin for treatment of patients with chronic Klebsiella infections].
    Titov LP; Shaban ZhG; Kartel' AI
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (5):46-9. PubMed ID: 11871301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.